Teleflex Incorporated (NYSE:TFX) Short Interest Update

Teleflex Incorporated (NYSE:TFX) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 712,200 shares, a decline of 19.8% from the March 31st total of 888,200 shares. Based on an average trading volume of 264,200 shares, the days-to-cover ratio is currently 2.7 days.

Insider Activity

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.43% of the company’s stock.

Hedge Funds Weigh In On Teleflex

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Kentucky Retirement Systems lifted its stake in shares of Teleflex by 1.1% during the 4th quarter. Kentucky Retirement Systems now owns 3,760 shares of the medical technology company’s stock valued at $938,000 after buying an additional 42 shares in the last quarter. Venturi Wealth Management LLC lifted its position in shares of Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock worth $46,000 after acquiring an additional 46 shares in the last quarter. Huntington National Bank boosted its holdings in shares of Teleflex by 26.5% in the third quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock worth $50,000 after acquiring an additional 53 shares during the period. KBC Group NV grew its position in shares of Teleflex by 1.8% in the fourth quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock valued at $791,000 after purchasing an additional 55 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Teleflex by 1.5% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 3,767 shares of the medical technology company’s stock valued at $740,000 after purchasing an additional 56 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of Teleflex stock traded up $1.77 on Monday, reaching $208.48. 502,328 shares of the company traded hands, compared to its average volume of 265,480. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.32 and a quick ratio of 1.29. The firm has a market capitalization of $9.82 billion, a PE ratio of 27.69, a PEG ratio of 1.98 and a beta of 1.11. The company has a 50 day moving average of $220.38 and a 200 day moving average of $226.18. Teleflex has a 52 week low of $177.63 and a 52 week high of $276.43.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating the consensus estimate of $3.26 by $0.12. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The business had revenue of $773.90 million during the quarter, compared to analyst estimates of $769.01 million. During the same period in the prior year, the company earned $3.52 earnings per share. Teleflex’s revenue was up 2.1% compared to the same quarter last year. Equities analysts forecast that Teleflex will post 13.73 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is presently 18.06%.

Analyst Ratings Changes

Several brokerages recently issued reports on TFX. Truist Financial decreased their price target on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Finally, Royal Bank of Canada decreased their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $267.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.